Non-steroidal anti-inflammatory drugs (NSAIDs) have the potential to prevent squamous cell carcinoma (SCC) and could be particularly beneficial to people at high risk of developing these cancers, according to scientists at QIMR Berghofer Medical Research Institute.
Squamous cell carcinoma is one of the most frequently occurring cancers world-wide.
Dr Catherine Olsen said, "Clinicians can now take this into consideration when prescribing anti-inflammatory medication for their patients with other sun-induced skin tumors who may be at high risk of SCC. There can be side-effects with both aspirin and other NSAID use - and people should talk to their general practitioner before taking any medication to reduce their skin cancer risk."
The study is published in the Journal of Investigative Dermatology.
Latest Cancer News
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
The mechanism by which the kinases cause inflammation has been discovered by scientists.